Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

Takeda’s Ninlaro knocked back by NICE for second time

September 5, 2017 Research and Development, Sales and Marketing Ninlaro, Takeda, biotech, drugs, pharma, pharmaceutical

NICE has revealed that the outcome of its consultation process for Ninlaro (ixazomib), Takeda’s treatment for relapsed or refractory multiple …
News

Pfizer’s drug back on the market after proving safety

September 5, 2017 Manufacturing and Production, Sales and Marketing Mylotarg, Pfizer, biotech, drugs, pharma, pharmaceutical

Back in 2000, Pfizer had a drug that was granted accelerated approval for the treatment of acute myeloid leukaemia (AML) …
News

Merck KGaA to streamline business with $1bn healthcare sale

September 5, 2017 Manufacturing and Production, Sales and Marketing GSK, Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA has revealed that it is looking to sell its consumer healthcare business, in order to refocus the business …
News

12% of the UK have hearts ten years older than they are, Public Health England finds

September 4, 2017 Research and Development, Sales and Marketing British Heart Foundation, Public Health England, cardiovascular disease, heart attack, heart health, stroke

New findings from Public Health England (PHE)’s Heart Age Test indicate that around 10% of men in the UK are …
News

Patently problematic? The impact of the Eli Lilly/Actavis intellectual property battle

September 4, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actavis, Eli Lilly, biotech, drugs, pemetrexed, pharma, pharmaceutical

The UK Supreme Court has sent shockwaves through the intellectual property world with its recent decision on Eli Lilly v …
Feature

NHS needs emergency £350 million to survive winter

September 4, 2017 Medical Communications, Sales and Marketing NHS, biotech, drugs, pharma, pharmaceutical

NHS Providers has stated that £350 million needs to be injected into the NHS to avoid the ‘humanitarian crisis’ that …
News

Takeda partners up to develop “next generation” CAR T solid tumour therapy

September 4, 2017 Research and Development, Sales and Marketing CAR T, CAR-T, Cancer, Noile-Immune, Takeda, pharma, pharmaceuticals

Takeda is set to partner with Noile-Immune Biotech in the development of a “next generation” chimeric antigen receptor T-cell (CAR …
News

Sanofi backs out of controversial Zika vaccine project

September 4, 2017 Research and Development, Sales and Marketing Sanofi, US, Vaccine, Zika, biotech, drugs, pharma, pharmaceutical

Sanofi’s development of a Zika vaccine, alongside the US’s Biomedical Advanced Research and Development Authority (BARDA), has hit the headlines …
News

Novartis CEO Jimenez announces retirement in 2018

September 4, 2017 Sales and Marketing Novartis, Vasant Narasimhan, joe jimenez, pharma, pharmaceuticals

Novartis has announced that its Chief Executive, Joe Jimenez (pictured), is set to retire next year. In his place, Vasant …
News

Top Ten most popular articles on Pharmafile.com this week

September 1, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Trump, drugs, health, life sciences, medicine, pharma, pharmaceutical, top ten

This week saw the news of a breakthrough in bispecific antibody production and Merck KGaA finally secured approval for its …
News

NICE rejects AstraZeneca’s breast cancer drug Faslodex

September 1, 2017 Medical Communications, Sales and Marketing AstraZeneca, Cancer, Faslodex, breast cancer, life sciences, pharma, pharmaceutical

NICE has announced its decision to not recommend AstraZeneca’s breast cancer drug Faslodex (fulvestrant) in women who have oestrogen-receptor-positive, locally …
News

FDA approves treatment to counter CAR-T side-effects

August 31, 2017 Medical Communications, Sales and Marketing Genentech, Roche, biotech, drugs, pharma, pharmaceutical

On the day that FDA announced the first CAR-T therapy would be given market authorisation, it also announced that a …
News

Has Trump’s power over pharma come to an end after Charlottesville?

August 31, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Donald Trump, J&J, JJ, Kenneth Frazier, MSD, President trump, Trump, life sciences, medicine, pharma, pharmaceuticals, president

In a shock move that was to have deeply resonant consequences, MSD Chairman and Chief Executive Officer Kenneth Frazier announced …
Feature

Lilly gets second shot at application for ‘blockbuster’ arthritis drug

August 31, 2017 Sales and Marketing Eli Lilly, arthritis, baricitinib, biotech, drugs, pharma, pharmaceutical

Earlier this year, Eli Lilly was on the receiving end of one of the most surprising setbacks in recent times …
News

Teva scores expanded indication for Austedo in tardive dyskinesia

August 31, 2017 Sales and Marketing FDA, Teva, medicine, pharma, pharmaceuticals

Following the FDA’s approval of Teva’s Austedo (deutetrabenazine) in the treatment of chorea associated with Huntington’s disease in April this …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026